Girija Goyal | Director in Advanced Technology Team
Wyss Institute Harvard University

Girija Goyal, Director in Advanced Technology Team, Wyss Institute Harvard University

Dr. Girija Goyal is an immunologist working with the organs-on-chips and diagnostics platforms to design better in vitro models of the human immune system to develop new immunotherapeutics and derisk vaccines. Her research has reached the real world as these in vitro models are now used at pharmaceutical companies and academic centers. Recently, she secured a prestigious Spark contract from ARPA-H Women’s Health Sprint to advance injected lymphoid organs as therapy for ovarian cancer. At the Wyss Institute, Girija also manages organ chip programs on diseases that affect the human intestine, lung and female reproductive tract.

Appearances:



Main Conference Day 2 - 10th March @ 16:40

Deep Dive Session: Non-animal preclinical systems for vaccine development and pandemic preparedness

3–4 short talks (10–12 min each) + moderated discussion/Q&A

·       Overview: Why non-animal systems now?

·       Organoids in preclinical vaccine research

·       Microphysiological systems / organ-on-chip platforms

·       Practical translation: integrating non-animal systems into development workflows

last published: 31/Aug/26 19:45 GMT

back to speakers